Shanghai Fengrui Venture Investment Center (Limited Partnership) was founded in 2015, and is a professional institution specializing in early-stage venture capital investment. It is dedicated to identifying and supporting the development of startups with strong innovation potential.

With early-stage investment as its core driver, the Company simultaneously deploys capital in growth-stage and mid-to-late-stage projects. Its investment strategy centers on three strategic pillars: consumer & TMT, hard technology, and biomedicine. Through in-depth resource integration, it has systematically invested in hundreds of innovative enterprises, building a diversified investment portfolio in cutting-edge fields such as artificial intelligence, intelligent manufacturing, and biotechnology. Its portfolio companies span multiple high-growth sectors, demonstrating exceptional industry insight and resource integration capabilities.

As an active capital platform, Fengrui leverages its acute sensitivity to emerging trends to provide invested companies with strategic guidance and extensive resource network support, thereby driving sustained value enhancement and long-term sustainable development.

Key portfolio companies include: Qingdao Zhiteng Technology Co., Ltd. (IPO), Nanjing Xinshijie Microelectronics Technology Co., Ltd. (IPO), and others.